Nucleotide Nutrition Ltd Accounts

The Director presents her report and accounts for the year ended 31 March 2019.

Principal activities

The principal activity of the company during the year under review was .





Director

The Director who served during the year was as follows:

R.L. Hoyle































































The above report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime as set out in Part 15 of the Companies Act 2006.


Signed on behalf of the board
........................................................................................................
R.L. Hoyle
Director
20 December 2019

at	31 March 2019
Company No.		07803653	2019	2018
			£	£



Fixed assets			1	1

Current assets			99,557	61,150

Creditors: Amounts falling due within one year			(142,928)	(105,773)
Net current liabilities			(43,371)	(44,623)
Total assets less current liabilities			(43,370)	(44,622)


Accruals and deferred income			(600)	(600)
			(43,970)	(45,222)


Capital and reserves			(43,970)	(45,222)

NOTES TO THE ACCOUNTS

1	Additional information



	Its registered number is:
	07803653

	Its registered office is:
	3 Gerlensta Court
	Bewdley
	Worcestershire

	DY12 1LS



These accounts have been prepared in accordance with the micro-entity provisions applicable to companies subject to the small companies regime of the Companies Act 2006.



For the year ended 31 March 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.

Approved by the board on 20 December 2019

And signed on its behalf by:

R.L. Hoyle
Director
20 December 2019